CD74 Is Expressed in Relapsed and Refractory Multiple Myeloma and Can be Targeted with a Novel Anti-CD74 Antibody Drug Conjugate, STRO-001

被引：0
|
作者：
Embry, Millicent
Li, Xiaofan
Yu, Abigail
Abrahams, Cristina
Greenland, Nancy Y.
Wen, Kwun Wah
Jones, Chris
DeAlmeida, Venita
Krimm, Stellanie
Krueger, Sarah
Matheny, Shannon
Kline, Toni
Yam, Alice
Stafford, Ryan
Wiita, Arun P.
Hallam, Trevor
Lupher, Mark
Molina, Arturo
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4420
引用
收藏
页数：3
相关论文
共 50 条
  • [41] A Dose Escalation Phase Ia Study of Anti-CD20 Antibody Drug Conjugate, MRG001 in Relapsed/Refractory Advanced Non-Hodgkin Lymphom
    Song, Yuqin
    Guo, Ye
    Wang, Zhao
    Wu, Meng
    Peng, Wei
    Sun, Lei
    Sun, Jinghui
    Li, Maggie
    Zhu, Jun
    BLOOD, 2021, 138
  • [42] Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma
    Stewart, A. Keith
    Krishnan, Amrita Y.
    Singhal, Seema
    Boccia, Ralph V.
    Patel, Manish R.
    Niesvizky, Ruben
    Chanan-Khan, Asher A.
    Ailawadhi, Sikander
    Brumm, Jochen
    Mundt, Kirsten E.
    Hong, Kyu
    McBride, Jacqueline
    Quyen Shon-Nguyen
    Xiao, Yuanyuan
    Ramakrishnan, Vanitha
    Polson, Andrew G.
    Samineni, Divya
    Leipold, Douglas
    Humke, Eric W.
    McClellan, James Scott
    Berdeja, Jesus G.
    BLOOD CANCER JOURNAL, 2019, 9 (2)
  • [43] Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma
    A. Keith Stewart
    Amrita Y. Krishnan
    Seema Singhal
    Ralph V. Boccia
    Manish R. Patel
    Ruben Niesvizky
    Asher A. Chanan-Khan
    Sikander Ailawadhi
    Jochen Brumm
    Kirsten E. Mundt
    Kyu Hong
    Jacqueline McBride
    Quyen Shon-Nguyen
    Yuanyuan Xiao
    Vanitha Ramakrishnan
    Andrew G. Polson
    Divya Samineni
    Douglas Leipold
    Eric W. Humke
    James Scott McClellan
    Jesus G. Berdeja
    Blood Cancer Journal, 9
  • [44] Letter phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma
    Lee, Hans C.
    Raje, Noopur S.
    Landgren, Ola
    Upreti, Vijay V.
    Wang, Jin
    Avilion, Ariel A.
    Hu, Xuguang
    Rasmussen, Erik
    Ngarmchamnanrith, Gataree
    Fujii, Hisaki
    Spencer, Andrew
    LEUKEMIA, 2021, 35 (01) : 255 - 258
  • [45] A Phase 1, Open-Label, Dose-Escalation Study of the Safety and Efficacy of Anti-CD38 Antibody Drug Conjugate (STI-6129) in Patients with Relapsed or Refractory Multiple Myeloma
    Chakraborty, Rajshekhar
    Yan, Ying
    Royal, Mike
    BLOOD, 2021, 138
  • [46] Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemia
    Jain, Nitin
    Stock, Wendy
    Zeidan, Amer
    Atallah, Ehab
    McCloskey, James
    Heffner, Leonard
    Tomlinson, Benjamin
    Bhatnagar, Bhavana
    Feingold, Jay
    Ungar, David
    Chao, Grace
    Zhang, Xiaoyan
    Qin, Yajuan
    Havenith, Karin
    Kantarjian, Hagop
    Wieduwilt, Matthew J.
    BLOOD ADVANCES, 2020, 4 (03) : 449 - 457
  • [47] Discovery and Preclinical Development of Novel CD74-Targeting Antibody-Drug Conjugates (ADCs) with Significant Activity in Multiple Myeloma (MM) Cell Lines and Xenograft Models
    Abrahams, Cristina
    Li, Xiaofan
    Yu, Abigail
    Krimm, Stellanie
    Kahana, Jason
    Narla, Rama Krishna
    Schwartz, Eric
    Boylan, John
    Hoffmann, Heidi
    Steiner, Alexander
    Zawada, James
    Stephenson, Heather
    Bruhns, Maureen
    DeAlmeida, Venita
    Matheny, Shannon
    Bussell, Stuart
    Galan, Adam
    Kline, Toni
    Vasquez, Nicki
    Yam, Alice
    Stafford, Ryan
    Heinsohn, Henry
    Sato, Aaron
    Molina, Arturo
    Hallam, Trevor
    Lupher, Mark, Jr.
    BLOOD, 2016, 128 (22)
  • [48] Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes
    Xavier Leleu
    Thomas Martin
    Katja Weisel
    Fredrik Schjesvold
    Shinsuke Iida
    Fabio Malavasi
    Salomon Manier
    Enrique M. Chang-Ki Min
    Charlotte Ocio
    Aurore Pawlyn
    Hang Perrot
    Joshua Quach
    Ivan Richter
    Kwee Spicka
    Paul G. Yong
    Annals of Hematology, 2022, 101 : 2123 - 2137
  • [49] Anti-CD38 antibody therapy for patients with relapsed/refractory multiple myeloma: differential mechanisms of action and recent clinical trial outcomes
    Leleu, Xavier
    Martin, Thomas
    Weisel, Katja
    Schjesvold, Fredrik
    Iida, Shinsuke
    Malavasi, Fabio
    Manier, Salomon
    Min, Chang-Ki
    Ocio, Enrique M.
    Pawlyn, Charlotte
    Perrot, Aurore
    Quach, Hang
    Richter, Joshua
    Spicka, Ivan
    Yong, Kwee
    Richardson, Paul G.
    ANNALS OF HEMATOLOGY, 2022, 101 (10) : 2123 - 2137
  • [50] Initial Dose Escalation of ISB 1442, a Novel CD38 Biparatopic x CD47 Bispecific Antibody, in Patients with Relapsed / Refractory Multiple Myeloma (RRMM)
    Kazandjian, Dickran
    Quach, Hang
    Sia, Hanlon
    Ho, Phoebe Joy
    Spencer, Andrew
    Schroeder, Mark A.
    Dhakal, Binod
    Cochrane, Tara
    Zonder, Jeffrey A.
    Yi, Nancy
    Duchesne, Dominique
    Shah, Tejas
    Garton, Andrew
    Menon, Vinu
    Gn, Sunitha
    Sammicheli, Stefano
    Zhukovsky, Eugene
    Konto, Cyril
    Pacaud, Lida
    Tan, Peter
    BLOOD, 2023, 142
12345